A recent Trump administration decision nudges health plans to do right by patients who struggle with high LDL, or “bad,” cholesterol.
Medicare Move Could Improve Treatment Access for Heart Patients
State legislatures can ensure heart patients have access to treatments
Heart Attacks, Strokes Follow Insurance Rejection
Cardiovascular Summit Spotlights Stories of Access Barriers, Risk and Heart Health
Sandeep Jauhar’s grandfather was sitting down to lunch with family when he crumpled to the floor. Jeff Kwitowski’s father was on a routine bike ride. Cat Davis Ahmed’s father was enjoying a game of tennis. And Florence Champagne was in an office building when she dropped to her knees, gasping for air and praying for her life.
What Heart Attack & Stroke Mean to EU Workplaces
Heart attack and stroke don’t just affect patients across Europe, new research reveals.
Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system
What Heart Patients' Experience Teaches us About Pharmacy Benefit Managers
On April 9, a congressional hearing will explore the impact of pharmacy benefit managers on high drug prices. It’s a connection that many heart patients have learned firsthand.
What EU Parliamentary Candidates Need to Know About Heart Health
IfPA Report Card: Health Plans Reject 1 in 3 High-Risk Heart Patients
New "Fast Facts" Highlights Impact of High Cholesterol on Europe
More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity. So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for Patient Access.
England Sets Sights on Heart Health
England has a plan. It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years. How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation.
A Cardiologist's Take on New Cholesterol-Lowering Guidelines
The outrage over insulin prices
Do prescription drug middlemen help keep prices high?
What Price Reductions for Cholesterol-lowering Medications Mean for Patients
Patient advocates across the country cheered this week as news spread about a decrease in the list price of evolocumab.
Poll: Health Plan Delays are “Unreasonable,” Dangerous for Heart Patients
These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?
Access, Disparities Issues Dominate Cardiovascular Health Policy Summit
A massive stroke marked a serious change in the weather for Mark McEwen, whose familiar face brought viewers the weather forecast on the 1990s’ “CBS This Morning.” McEwen keynoted the May 15 Cardiovascular Health Policy Summit in Washington, DC, describing how he struggled to regain speech, mobility and fine motor skills.
Drug Approval Signals New Options for Stroke, Heart Attack Survivors in Europe
Heart patients in Europe have something to celebrate.
